临床外科杂志 ›› 2024, Vol. 32 ›› Issue (7): 721-724.doi: 10.3969/j.issn.1005-6483.2024.07.014

• 论著 • 上一篇    下一篇

长链非编码RNA脑源性神经营养因子反义物和信号素3B反义物1在胃癌病人中的表达及联合超声检查在胃癌诊断中的应用

李爱华 刘浪 张玲丽 段迪 王邓超   

  1. 641400 四川省简阳市中医医院超声医学科(李爱华、刘浪、张玲丽),普外科(段迪);四川省自贡市第四人民医院普外科(王邓超)
  • 收稿日期:2023-07-31 出版日期:2024-07-20 发布日期:2024-07-20
  • 通讯作者: 李爱华,Email:15308393115@163.com
  • 基金资助:
    四川省医学会科研项目(Q22071)

Expression of long non-coding RNA brain-derived neurotrophic factor-antisense and semaphorin 3B-antisense 1 in gastric cancer patients and the application of them combined ultrasound in the diagnosis of gastric cancer

LI Aihua,LIU Lang,ZHANG Lingli,DUAN Di,WANG Dengchao   

  1. Department of Ultrasound Medicine,Jianyang Chinese Medicine Hospital,Sichuan,Jianyang 641400,China
  • Received:2023-07-31 Online:2024-07-20 Published:2024-07-20

摘要: 目的 探究长链非编码RNA(lncRNA)脑源性神经营养因子-反义物(BDNF-AS)和信号素3B-反义物1(SEMA3B-AS1)在胃癌病人中的表达及联合超声检查在胃癌诊断中的应用价值。方法 2021年1月~2023年2月收治的118例胃癌病人为胃癌组,同期113例胃部良性病变者为良性病变组。实时荧光定量PCR(qRT-PCR)检测血清BDNF-AS和SEMA3B-AS1表达水平,并以平均值分为BDNF-AS高表达组(55例)和BDNF-AS低表达组(63例)、SEMA3B-AS1高表达组(57例)和SEMA3B-AS1低表达组(61例);Kappa检验分析超声诊断与临床病理诊断的一致性;受试者工作特征曲线(ROC)分析血清BDNF-AS和SEMA3B-AS1联合超声对胃癌的诊断价值。结果 与良性病变组比较,胃癌组血清BDNF-AS和SEMA3B-AS1水平均明显下降(t=10.205,t=9.590,P<0.05);BDNF-AS和SEMA3B-AS1在肿瘤直径≥3 cm、浸润深度较深、分化程度较低、发生淋巴结转移的胃癌病人中表达水平明显较低(P<0.05);Kappa检验结果显示,超声诊断与临床病理诊断的一致性较高(Kappa值=0.723,P<0.05);ROC结果显示,血清BDNF-AS、SEMA3B-AS1水平和超声诊断胃癌的AUC分别为0.848、0.835、0.861,三者联合诊断的AUC(0.949)显著大于血清BDNF-AS单独诊断的AUC(Z=4.713,P=0.000)、血清SEMA3B-AS1水平单独诊断的AUC(Z=4.112,P=0.001 5)和超声诊断的AUC(Z=3.350,P=0.000 8),联合诊断的敏感度、特异度优于三者单独诊断。结论 血清BDNF-AS和SEMA3B-AS1联合超声检查在胃癌的诊断上具有较高的应用价值。

关键词: 胃癌, 超声, 长链非编码RNA, 脑源性神经营养因子-反义物, 信号素3B-反义物1, 诊断

Abstract: Objective To investigate the expression of long non-coding RNA (lncRNA) brain-derived neurotrophic factor-antisense (BDNF-AS) and semaphorin 3B-antisense 1 (SEMA3B-AS1) in patients with gastric cancer and the application value of combined ultrasound in the diagnosis of gastric cancer.Methods From January 2021 to February 2023,118 gastric cancer patients admitted to our hospital were retrospectively selected as the gastric cancer group,another 113 cases with benign gastric lesions in our hospital were as the benign lesion group.Real-time fluorescence quantitative PCR (qRT-PCR) was applied to detect the expression levels of serum BDNF-AS and SEMA3B-AS1,and patients were divided into BDNF-AS high expression group (n=55) and BDNF-AS low expression group (n=63),SEMA3B-AS1 high expression group (n=57),and SEMA3B-AS1 low expression group (n=61) based on the average value;Kappa test was applied to analyze the consistency between ultrasound diagnosis and clinical pathological diagnosis;receiver operating characteristic curve (ROC) was applied to analyze the diagnostic value of serum BDNF-AS and SEMA3B-AS1 combined with ultrasound for gastric cancer.Results Compared with the benign lesion group,the serum levels of BDNF-AS and SEMA3B-AS1 in the gastric cancer group were obviously lower (t=10.205,t=9.590,P<0.05);the expression levels of BDNF-AS and SEMA3B-AS1 were obviously lower in gastric cancer patients with tumor diameter ≥ 3 cm,deeper infiltration depth,lower differentiation,and lymph node metastasis (P<0.05);Kappa test results showed a high consistency between ultrasound diagnosis and clinical pathological diagnosis (Kappa value=0.723,P<0.05);ROC results showed that the AUC of serum levels of BDNF-AS,SEMA3B-AS1,and ultrasound in diagnosis of gastric cancer was 0.848,0.835,and 0.861,respectively,the AUC (0.949) diagnosed by the combination of the three was obviously higher than that diagnosed by serum BDNF-AS alone (Z=4.713,P=0.000),serum SEMA3B-AS1 level alone (Z=4.112,P=0.001 5),and ultrasound diagnosis (Z=3.350,P=0.000 8),the sensitivity and specificity of the combined diagnosis were superior to those diagnosed by the three alone.Conclusion The combination of serum BDNF-AS and SEMA3B-AS1 ultrasound has high practical value in the diagnosis of gastric cancer.

Key words: gastric cancer, ultrasound, long non-coding RNA, brain-derived neurotrophic factor-antisense, semaphorin 3B-antisense 1, diagnosis

[1] 姜尚昆 郭丰富. 腹膜后巨大肾上腺表皮样囊肿一例[J]. 临床外科杂志, 2024, 32(7): 686-687.
[2] 刘丽君 于海燕. 老年胃癌腹腔镜根治术后肺部感染的影响因素分析[J]. 临床外科杂志, 2024, 32(7): 725-728.
[3] 孟令胜 孔德华 王见斌. 床旁胃肠超声指导ICU急性胃肠损伤危重患者肠内营养治疗的应用价值[J]. 临床外科杂志, 2024, 32(7): 729-732.
[4] 张凯 张强 范槐喜 李旭升 刘华. 大腿巨大混合性脂肪肉瘤一例[J]. 临床外科杂志, 2024, 32(7): 771-772.
[5] 马慧心 亚云锦 金焰 王正佳 邓世康. 成人胰母细胞瘤伴肝转移一例[J]. 临床外科杂志, 2024, 32(7): 783-784.
[6] 袁青 崔旭蕾 谭刚. 中国麻醉医生超声引导下椎管内穿刺技术的临床应用与培训需求调查[J]. 临床外科杂志, 2024, 32(6): 575-579.
[7] 白冰 唐帅 张越伦 申乐. 术中肋间神经阻滞与术前超声引导下椎旁阻滞对胸腔镜肺部手术病人术后并发症的影响分析[J]. 临床外科杂志, 2024, 32(6): 581-585.
[8] 朱欣艳 时蓉 徐松超 李慧莉 邵沛琪 王云. 改良肋下腰方肌前侧阻滞用于腹腔镜肾脏切除术后镇痛的临床效果研究[J]. 临床外科杂志, 2024, 32(6): 587-591.
[9] 高超 戴希勇 蒋钰辉 刘小玉 李晶 熊浩. 非小细胞肺癌病人血清中miR-455、miR-383表达水平及其临床诊断价值分析[J]. 临床外科杂志, 2024, 32(6): 607-610.
[10] 仲洁 廖刃. 区域阻滞技术在无阿片类药物麻醉中的应用进展[J]. 临床外科杂志, 2024, 32(6): 661-663.
[11] 谢秋毅 张强 陈勇 孙帅 钱建军 姚捷 李振南. 腹部卒中:胰十二指肠下动脉出血一例[J]. 临床外科杂志, 2024, 32(6): 585-586.
[12] 尹英爱 秦桂萍 华玉兰 曹敏 齐淋喆 白苏日娜 杨悦. 伴AFP明显升高的高级别胎儿型肺腺癌一例[J]. 临床外科杂志, 2024, 32(6): 619-620.
[13] 秦飞 李帆. 重型颅脑损伤病人血清微小RNA-542-3p、长链非编码RNA牛磺酸上调基因1表达及其与预后的关系[J]. 临床外科杂志, 2024, 32(5): 472-475.
[14] 杨丽 马强 张春霞 郑永财 张辉. 超声造影体表定位联合纳米炭示踪行前哨淋巴结活检在cN0期浸润性乳腺癌病人中的应用分析[J]. 临床外科杂志, 2024, 32(5): 476-479.
[15] 张慧 张萍 郭汝 何娅娜. 胃癌术后辅助化疗期间恶心呕吐风险预测模型的建立及验证[J]. 临床外科杂志, 2024, 32(5): 484-488.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 邱江. 心脏死亡捐献供肾移植免疫抑制方案的选择[J]. 临床外科杂志, 2016, 24(10): 735 .
[2] 林俊. 原发性中枢神经系统恶性肿瘤供者在器官移植中的应用[J]. 临床外科杂志, 2016, 24(10): 737 .
[3] 杨华;李新长;龙成美;等. 公民逝世后器官捐献供肾移植临床分析[J]. 临床外科杂志, 2016, 24(10): 747 .
[4] 胡志伟;汪忠镐;张玉;等. 腹腔镜Toupet胃底折叠术治疗干燥综合征合并严重胃食管反流病两例[J]. 临床外科杂志, 2016, 24(10): 766 .
[5] 李义亮;张成;克力木;等. 完全腹腔镜下远端胃癌根治术的临床体会[J]. 临床外科杂志, 2016, 24(10): 769 .
[6] 张忠伟;刘扬;路明. 痔上黏膜环切术治疗直肠前突所致出口梗阻型便秘的疗效观察[J]. 临床外科杂志, 2016, 24(10): 774 .
[7] 安永德;李新源;郭亚民;等. 腹腔镜下胆囊切除术中转开腹74例临床分析[J]. 临床外科杂志, 2016, 24(10): 758 .
[8] 张业强;晏大学;高小见 . 急诊肋骨内固定手术对严重连枷胸患者恢复的影响[J]. 临床外科杂志, 2016, 24(10): 794 .
[9] 危常鹏 . 原发性乳腺淋巴瘤一例[J]. 临床外科杂志, 2016, 24(10): 806 .
[10] 石汉平. 胃癌围手术期营养治疗[J]. 临床外科杂志, 2016, 24(11): 821 .